Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apricoxib with Lapatinib and Capecitabine in HER2+ Breast Cancer
NCT00657137Phase 2Terminated
- Sponsor
- Adastra Pharmaceuticals
- Start
- Apr 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apricoxib in HER2-positive breast cancer, sponsored by Adastra Pharmaceuticals. Started Apr 2008; status: terminated.
02
Drugs
apricoxib
03
Conditions
HER2-positive breast cancer
Beyond the preview
Go deeper on NCT00657137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657137.